Nuclear
lamins are involved in many cellular functions due to their ability to bind numerous partners including
chromatin and
transcription factors, and affect their properties. Dunnigan type
familial partial lipodystrophy (FPLD2; OMIM#151660) is caused in most cases by the A-type
lamin R482W mutation. We report here that the R482W mutation affects the regulatory activity of
sterol response element
binding protein 1 (SREBP1), a
transcription factor that regulates hundreds of genes involved in lipid metabolism and adipocyte differentiation. Using in situ proximity
ligation assays (PLA), reporter assays and biochemical and transcriptomic approaches, we show that interactions of SREBP1 with
lamin A and
lamin C occur at the nuclear periphery and in the nucleoplasm. These interactions involve the Ig-fold of A-type
lamins and are favored upon SREBP1 binding to its
DNA target sequences. We show that SREBP1, LMNA and
sterol response
DNA elements form ternary complexes in vitro. In addition, overexpression of A-type
lamins reduces transcriptional activity of SREBP1. In contrast, both overexpression of LMNA R482W in primary human preadipocytes and endogenous expression of A-type
lamins R482W in FPLD2 patient fibroblasts, reduce A-type lamins-SREBP1 in situ interactions and upregulate a large number of SREBP1 target genes. As this LMNA mutant was previously shown to inhibit adipogenic differentiation, we propose that deregulation of SREBP1 by mutated A-type
lamins constitutes one underlying mechanism of the physiopathology of FPLD2. Our data suggest that SREBP1 targeting molecules could be considered in a therapeutic context.